High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun   Kim Yeul Hong   Kim Jun Suk   Seo Jae Hong  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite

High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival

By S. Johansen J.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 1, 2003-07 ,pp. : 15-21

Springer Publishing Company

Access to resources Recommend Favorite

Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer

By          

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 940-944

Spandidos Publications

Access to resources Recommend Favorite

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

By Svane Inge   Pedersen Anders   Johansen Julia   Johnsen Hans   Nielsen Dorte   Kamby Claus   Ottesen Svend   Balslev Eva   Gaarsdal Eva   Nikolajsen Kirsten   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1485-1499

Springer Publishing Company

Access to resources Recommend Favorite

A new emergency in oncology: Bone metastases in breast cancer patients (Review)

By      

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 306-310

Spandidos Publications

Access to resources Recommend Favorite